Kenneth Kwok

2.1k citations

60 papers · 1.6k indexed · 2 hit papers · h-index 18

Rheumatology top 1%
Hematology top 2%
Oncology top 10%
Immunology top 10%
Genetics top 5%

Co-authors: Lisy Wang Ryan DeMasi Stanley Cohen Koshika Soma Christina Charles‐Schoeman J. Wollenhaupt Richard J. Riese Jeffrey R. Curtis
Topics: Rheumatoid Arthritis Research and Therapies (35 papers)Autoimmune and Inflammatory Disorders Research (20 papers)Chronic Lymphocytic Leukemia Research (15 papers)
Cited by: Rheumatology Hematology Genetics
Journals: Gastroenterology Annals of the Rheumatic Diseases The American Journal of Gastroenterology
Partner nations: United States Germany United Kingdom

In The Last Decade

Kenneth Kwok

56 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

2017 302 citations Stanley Cohen, Yoshiya Tanaka et al. Annals of the Rheumatic Diseases profile →
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

2022 123 citations Christina Charles‐Schoeman, Maya H Buch et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Kenneth Kwok

Since Specialization

Citations

This map shows the geographic impact of Kenneth Kwok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Kwok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Kwok more than expected).

Fields of papers citing papers by Kenneth Kwok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Kwok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Kwok. The network helps show where Kenneth Kwok may publish in the future.

Co-authorship network of co-authors of Kenneth Kwok

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Kwok. A scholar is included among the top collaborators of Kenneth Kwok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Kwok. Kenneth Kwok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies 2024 ·Rheumatology and Therapy ·Xenofon Baraliakos,(unknown),Kenneth Kwok,Bonnie Vlahos,(unknown)	1
2	Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study 2024 ·RMD Open ·Maya H Buch,Deepak L. Bhatt,Christina Charles‐Schoeman,Jon T. Giles,Ted R. Mikuls,Gary G. Koch,Steven R. Ytterberg,(unknown),(unknown),Kenneth Kwok,Carol A. Connell,(unknown),(unknown)	8
3	Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme 2023 ·Journal of Crohn s and Colitis ·Stefan Schreiber,David T. Rubin,Siew C. Ng,Laurent Peyrin‐Biroulet,Silvio Danese,Irene Modesto,Xiang Guo,Chinyu Su,Kenneth Kwok,(unknown),(unknown),Arne Yndestad,Walter Reinisch,Marla C. Dubinsky	17
4	Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis 2023 ·Rheumatology and Therapy ·Gerd R Burmester,Laura C. Coates,Stanley Cohen,Yoshiya Tanaka,Ivana Vranić,(unknown),Irina Lazariciu,(unknown),Kenneth Kwok,Lara Fallon,(unknown)	6
5	Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start 2023 ·Arthritis Research & Therapy ·Adrian Ciurea,Oliver Distler,Kenneth Kwok,(unknown),Lisy Wang,Tim Killeen,Caroline Ospelt,Mojca Frank‐Bertoncelj	4
6	Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs 2022 ·Rheumatology and Therapy ·Kevin Winthrop,Arne Yndestad,Dan Henrohn,Silvio Danese,Sara Marsal,María Galindo-Izquierdo,John Woolcott,(unknown),Kenneth Kwok,Andrea Shapiro,Thomas V. Jones,(unknown),Chinyu Su,Julián Panés,Stanley Cohen	3
7	Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel) 2022 ·Clinical Rheumatology ·Ruediger B. Müeller,Hendrik Schulze‐Koops,Daniel E. Furst,Stanley Cohen,Kenneth Kwok,Lisy Wang,Tim Killeen,Johannes von Kempis	3
8	S775 Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program 2022 ·The American Journal of Gastroenterology ·Stefan Schreiber,David T. Rubin,Siew C. Ng,(unknown),Xiang Guo,(unknown),Kenneth Kwok,(unknown),Yan Chen,Arne Yndestad,Walter Reinisch,Marla C. Dubinsky	0
9	Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment 2021 ·Rheumatology and Therapy ·Kevin Winthrop,Jeffrey R. Curtis,Kunihiro Yamaoka,Eun Bong Lee,Tomohiro Hirose,Jose L. Rivas,Kenneth Kwok,Gerd R Burmester	12
10	Tu1866 EFFICACY AND SAFETY OF AN ADDITIONAL 8 WEEKS OF TOFACITINIB INDUCTION THERAPY: UPDATED RESULTS OF THE OCTAVE OPEN STUDY FOR TOFACITINIB 8-WEEK INDUCTION NON-RESPONDERS 2020 ·Gastroenterology ·David T. Rubin,Marla C. Dubinsky,Silvio Danese,Rogério Saad-Hossne,Darío Ponce de León,Eric S. Maller,Nervin Lawendy,Kenneth Kwok,Chinyu Su	1
11	Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials 2020 ·Digestive Diseases and Sciences ·Remo Panaccione,John D. Isaacs,Lea Ann Chen,Wenjin Wang,Amy Marren,Kenneth Kwok,Lisy Wang,(unknown),Chinyu Su	1
12	Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials 2020 ·Digestive Diseases and Sciences ·Remo Panaccione,John D. Isaacs,Lea Ann Chen,Wenjin Wang,Amy Marren,Kenneth Kwok,Lisy Wang,Gary Chan,Chinyu Su	11
13	Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study 2019 ·Arthritis Research & Therapy ·J. Wollenhaupt,(unknown),Jeffrey R. Curtis,Joel C. Silverfield,Ketti K. Terry,Koshika Soma,(unknown),Ryan DeMasi,Sander Strengholt,Kenneth Kwok,Irina Lazariciu,Lisy Wang,Stanley Cohen	238
14	Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses 2018 ·Rheumatology and Therapy ·Vibeke Strand,Arthur Kavanaugh,Alan Kivitz,Désirée van der Heijde,Kenneth Kwok,Ermeg L. Akylbekova,(unknown),(unknown),Carol A. Connell,Eustratios Bananis,Josef S Smolen	9
15	Assessment of Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Data from an Open-Label Long-Term Extension Study over 3 Years 2017 ·Arthritis & Rheumatism ·D. van der Heijde,J. Wollenhaupt,Stanley Cohen,Sander Strengholt,Ketti K. Terry,Ryan DeMasi,Kenneth Kwok,Irina Lazariciu,(unknown)	3
16	Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies 2016 ·Lara D. Veeken ·Hendrik Schulze‐Koops,Vibeke Strand,Chudy I. Nduaka,Ryan DeMasi,Gene V. Wallenstein,Kenneth Kwok,Lisy Wang	69
17	Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor 2016 ·Seminars in Arthritis and Rheumatism ·Christina Charles‐Schoeman,Pierre Wicker,Miguel Á. González‐Gay,M. Boy,Andrea Zuckerman,Koshika Soma,Jamie Geier,Kenneth Kwok,Richard J. Riese	111
18	Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs 2015 ·Annals of the Rheumatic Diseases ·Christina Charles‐Schoeman,Gerd R Burmester,Peter Nash,Cristiano A. F. Zerbini,Koshika Soma,Kenneth Kwok,Thijs Hendrikx,Eustratios Bananis,Roy Fleischmann	59
19	Referral source, symptoms, and severity at diagnosis of ocular hypertension or open-angle glaucoma in various practices 2012 ·Canadian Journal of Ophthalmology ·Yvonne M. Buys,Rania Gaspo,Kenneth Kwok	15
20	Ascorbic acid inhibits ROS production, NF-?B activation and prevents ethanol-induced growth retardation and microencephaly 2005 ·Neuropharmacology ·Peng You,Kenneth Kwok,Pengfei Yang,Sophia Ng,(unknown),O Wong,Ming‐Liang He,Harold H. Kung,Muh-Shi Lin	100

About Kenneth Kwok

Kenneth Kwok is a scholar working on Rheumatology, Hematology and Genetics, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (35 papers), Autoimmune and Inflammatory Disorders Research (20 papers) and Chronic Lymphocytic Leukemia Research (15 papers). The work is most often cited by research in Rheumatology (973 citations), Hematology (480 citations) and Genetics (220 citations). Kenneth Kwok has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Lisy Wang, Ryan DeMasi, Stanley Cohen, Koshika Soma, Christina Charles‐Schoeman, J. Wollenhaupt, Richard J. Riese, Jeffrey R. Curtis, Peter Nash and Jamie Geier. Their work appears in journals such as Gastroenterology, Annals of the Rheumatic Diseases and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact